Back
Speaker illustration

Doctor Yuling Hsu

National Cheng Kung University Hospital, Tainan (Taiwan)

Presentations

Sacubitril/valsartan in primary prevention of cancer-therapy related cardiac dysfunction in breast cancer patients.

Event: ESC Congress 2024

Topic: Cardio-Oncology

Session: Smaller trials: cardiac function and remodelling

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources